Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Waschbisch, Anne ^a   Atiya, Monika ^a   Linker, Ralf A ^a   Potapov, Sergej ^a   Schwab, Stefan ^a   Derfuss, Tobias ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; INTERFERON BETA SERINE; MICRORNA; MICRORNA 142 3P; MICRORNA 146A; MICRORNA 155; MICRORNA 326; UNCLASSIFIED DRUG; PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; CASE CONTROL STUDY; CLINICAL TRIAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; MONONUCLEAR CELL;

CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOMODULATION; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PEPTIDES;

EID: 80052853319     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024604     Document Type: Article

References (23)

1. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, et al. (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10: R101.
2. Tang Y, Luo X, Cui H, Ni X, Yuan M, et al. (2009) MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60: 1065-1075.
3. Alevizos I, Alexander S, Turner RJ, Illei GG, (2011) MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjogren's syndrome. Arthritis Rheum 63: 535-544.
4. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
5. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D, (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10: 111-122.
6. Junker A, Hohlfeld R, Meinl E, (2011) The emerging role of microRNAs in multiple sclerosis. Nat Rev Neurol 7: 56-59.
7. Tufekci KU, Oner MG, Genc S, Genc K, (2011) MicroRNAs and Multiple Sclerosis. Autoimmune Dis2011.
8. Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, et al. (2010) MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 5: e12132.
9. De Santis G, Ferracin M, Biondani A, Caniatti L, Rosaria Tola M, et al. (2010) Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol 226: 165-171.
10. Du C, Liu C, Kang J, Zhao G, Ye Z, et al. (2009) MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 10: 1252-1259.
11. Keller A, Leidinger P, Lange J, Borries A, Schroers H, et al. (2009) Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 4: e7440.
12. Lindberg RL, Hoffmann F, Mehling M, Kuhle J, Kappos L, (2010) Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. Eur J Immunol 40: 888-898.
13. Otaegui D, Baranzini SE, Armananzas R, Calvo B, Munoz-Culla M, et al. (2009) Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 4: e6309.
14. O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, et al. (2010) MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33: 607-619.
15. Huang B, Zhao J, Lei Z, Shen S, Li D, et al. (2009) miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep 10: 180-185.
16. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, et al. (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142: 914-929.
17. Nakasa T, Miyaki S, Okubo A, Hashimoto M, Nishida K, et al. (2008) Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 58: 1284-1292.
18. Sonkoly E, Wei T, Janson PC, Saaf A, Lundeberg L, et al. (2007) MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2: e610.
19. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, et al. (2009) MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132: 3342-3352.
20. Burger D, Molnarfi N, Weber MS, Brandt KJ, Benkhoucha M, et al. (2009) Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis. Proc Natl Acad Sci U S A 106: 4355-4359.
21. Racke MK, Lovett-Racke AE, (2011) Glatiramer acetate treatment of multiple sclerosis: an immunological perspective. J Immunol 186: 1887-1890.
22. Weber MS, Starck M, Wagenpfeil S, Meinl E, Hohlfeld R, et al. (2004) Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo. Brain 127: 1370-1378.
23. Team RDC (2011) R: A language and environment for statistical computing. Vienna, Austria R Foundation for Statistical Computing ISBN 3-900051-07-0, Available: http://www.R-project.org/.